Clinical Trials in Massachusetts

Showing 3561-3580 of 15,316 trials

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

NCT06202274

This is a non-randomized, multi-center, open-label, prospective clinical study evaluating the clinical treatment with Candela Medical Technology.

Hair ReductionTattoo RemovalWrinkle+4 more

Candela Corporation500 participantsStarted Oct 2023

Jacksonville, Florida, United States • Marlborough, Massachusetts, United States • Yokneam Illit, Israel

Active Not RecruitingNA8.1 miles

Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

NCT06064071

Clinical Study Evaluating Nordlys™ System with Selective Waveband Technology (SWT)® Intense Pulsed Light (IPL) Applicators for Dry Eye Disease (DED) due to Meibomian Gland Dysfunction (MGD).

Meibomian Gland DysfunctionDry Eye Disease

Candela Corporation100 participantsStarted Sep 2023

Miami, Florida, United States • Marlborough, Massachusetts, United States • Buenos Aires, Argentina

COMPLETEDPhase 314 miles

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

NCT04057573

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adolescent and adult participants with non-segmental vitiligo for whom total body involved vitiligo area (facial and nonfacial) does not exceed 10% body surface area (BSA).

Non-segmental Vitiligo

Incyte Corporation344 participantsStarted Oct 2019

Gilbert, Arizona, United States • Fremont, California, United States • Irvine, California, United States +73 more locations

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

Find Trials by Condition in Massachusetts

Berries, Bugs, and the Blues

ERG Components in Schizophrenia and Bipolar Disorder Type I

Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Study of JK07 in Patients With Chronic Heart Failure

The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

The Rhode Island Prescription and Illicit Drug Study

A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)

Study to Assess Efficacy and Safety of Bulevirtide in Participants With Chronic Hepatitis Delta (CHD)

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)